(Total Views: 361)
Posted On: 03/26/2018 10:19:19 PM
Post# of 99141
$CELZ: NEW UPDATED 03/26/18 DD PACKAGE~~A clinical-stage biotechnology company focused on Urology and Neurology using stem cell treatments.
CLICK HERE TO VISIT THE CREATIVE MEDICAL TECHNOLOGY HOLDING, INC WEBSITE
ERECTILE DYSFUNCTION CLINICAL TRIALS
Why 2018 Could Be An Explosive Year For Biotech Mergers
https://www.investors.com/news/technology/why...h-mergers/
$11 billion biotech binge fuels forecasts of 2018 M&A surge
https://www.reuters.com/article/uk-biotech-m-...SKBN1EX1KF
Why 2018 is a make-or-break year for pharma
Many drugmakers have neglected their pipelines, and will look to acquisitions to bolster them
https://www.marketwatch.com/story/why-2018-is...2017-12-19
Tax Overhaul Could Jolt Dollar as U.S. Companies Bring Home Cash
Corporations could repatriate as much as $400 billion in earnings and cash from abroad
https://www.wsj.com/articles/tax-overhaul-cou...1514206800
CLICK HERE FOR MORE NEWS
Creative Medical Technology Holdings, Inc. To Unveil Its Patented CaverStem™ Procedure For Erectile Dysfunction At International Urology Conference
Press Release | 03/26/2018
Creative Medical Technology Holdings Licenses Intellectual Property from Internationally Renowned Neurologist and Creates Neurology Focused Stem Cell Subsidiary
Press Release | 02/20/2018
Stem Cells as Medicine: The Promise of Universal Donor Adult Stem Cells Continues to Attract Optimism
Press Release | 12/20/2017
"Urologist to the Stars" Dr. Alexander Gershman Begins Treating Patients with Patented Caverstem™ Stem Cell Procedure for Drug Refractory Erectile Dysfunction
Press Release | 12/18/2017
Creative Medical Technology Holdings Recruits Top Urologists for Caverstem™ Stem Cell Treatment of Erectile Dysfunction
Press Release | 12/14/2017
CLICK HERE TO VISIT THE CREATIVE MEDICAL TECHNOLOGY HOLDING, INC WEBSITE
ERECTILE DYSFUNCTION CLINICAL TRIALS
Why 2018 Could Be An Explosive Year For Biotech Mergers
https://www.investors.com/news/technology/why...h-mergers/
$11 billion biotech binge fuels forecasts of 2018 M&A surge
https://www.reuters.com/article/uk-biotech-m-...SKBN1EX1KF
Why 2018 is a make-or-break year for pharma
Many drugmakers have neglected their pipelines, and will look to acquisitions to bolster them
https://www.marketwatch.com/story/why-2018-is...2017-12-19
Tax Overhaul Could Jolt Dollar as U.S. Companies Bring Home Cash
Corporations could repatriate as much as $400 billion in earnings and cash from abroad
https://www.wsj.com/articles/tax-overhaul-cou...1514206800
CLICK HERE FOR MORE NEWS
Creative Medical Technology Holdings, Inc. To Unveil Its Patented CaverStem™ Procedure For Erectile Dysfunction At International Urology Conference
Press Release | 03/26/2018
Creative Medical Technology Holdings Licenses Intellectual Property from Internationally Renowned Neurologist and Creates Neurology Focused Stem Cell Subsidiary
Press Release | 02/20/2018
Stem Cells as Medicine: The Promise of Universal Donor Adult Stem Cells Continues to Attract Optimism
Press Release | 12/20/2017
"Urologist to the Stars" Dr. Alexander Gershman Begins Treating Patients with Patented Caverstem™ Stem Cell Procedure for Drug Refractory Erectile Dysfunction
Press Release | 12/18/2017
Creative Medical Technology Holdings Recruits Top Urologists for Caverstem™ Stem Cell Treatment of Erectile Dysfunction
Press Release | 12/14/2017
(0)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.
